Showing results (561-570 of 3,934) with videos related to

Sort By:
Pageof 394
American Journal of Cancer Research|October 18, 2021
Erratum: Cilostazol eliminates radiation-resistant glioblastoma by re-evoking big conductance calcium-activated potassium channel activityChan-Chuan Liu, Cheng-Lin Wu, I-Chun Yeh, et al.
American Journal of Cancer Research|July 10, 2019
Optimal treatments for cervical adenocarcinomaSzu-Yuan Wu, Eng-Yen Huang, Hao Lin
American Journal of Cancer Research|July 10, 2019
How to train a mouse-methodological issues in pre-clinical exercise oncologyLuma Melo, Amit Hagar
American Journal of Cancer Research|July 10, 2019
Induction of autophagy-dependent apoptosis in cancer cells through activation of ER stress: an uncovered anti-cancer mechanism by anti-alcoholism drug disulfiramXiao Zhang, Pan Hu, Shi-Ying Ding, et al.
American Journal of Cancer Research|March 9, 2022
Intratumoral lymphatic endothelial cell infiltration reflecting lymphangiogenesis is counterbalanced by immune responses and better cancer biology in the breast cancer tumor microenvironmentRongrong Wu, Joy Sarkar, Yoshihisa Tokumaru, et al.
American Journal of Cancer Research|March 9, 2022
Trastuzumab in combination with PEGylated interferon-α1b exerts synergistic antitumor activity through enhanced inhibition of HER2 downstream signaling and antibody-dependent cellular cytotoxicityPiaopiao Xu, Xiangling Chen, Yongping Xu, et al.
American Journal of Cancer Research|March 9, 2022
Multimodality imaging in the assessment of bone marrow-derived mesenchymal stem cell therapy for doxorubicin-induced cardiomyopathyChanjuan Qu, Jian Wang, Yuqing Wang, et al.
American Journal of Cancer Research|March 9, 2022
PBX4 functions as a potential novel oncopromoter in colorectal cancer: a comprehensive analysis of the PBX gene familyEirini G Martinou, Carla S Moller-Levet, Angeliki M Angelidi
American Journal of Cancer Research|March 9, 2022
MUC20 as a novel prognostic biomarker in ccRCC correlating with tumor immune microenvironment modulationBo Xue, Wen-Min Guo, Jie-Dong Jia, et al.
American Journal of Cancer Research|March 9, 2022
Semaphorin 4C promotes motility and immunosuppressive activity of cancer cells via CRMP3 and PD-L1Yu-Hsuan Hung, Ming-Derg Lai, Wen-Chun Hung, et al.
Pageof 394